Vascular Occlusion Crossing Systems

Definition : Systems designed for use in crossing through chronic total occlusions (CTO) in the vasculature (usually in the arteries) using high-frequency mechanical vibrations. These systems typically consist of a high-frequency generator (e.g., 20 kHz), ultrasound transducers to produce mechanical vibration from the electrical power, a sterile powered injector for irrigation (e.g., saline) of the catheter, and a single-use switch-activated catheter with a core wire that transmits the vibrations to the tip of the catheter. Also available are vascular occlusion crossing systems typically including dedicated catheters according to the intended use (e.g., coronary or peripheral arteries). The systems are used to facilitate guidewire passage across the CTO, permitting subsequent angioplasty procedures and/or stent placement; they are typically mounted on an intravenous pole.

Entry Terms : "Crossers, Vascular" , "Crossing Systems, Vascular Occlusion" , "Guidewire Occlusion Crossing Systems, Peripheral Artery" , "Occlusion Crossing Systems, Vascular" , "Recanalization Vascular Systems"

UMDC code : 27191

U.S.companies only
Suppress Subsidiary Companies

1-4 of 4 Match(es).


Company Type: Parent

Arstasis develops innovative vascular access devices designed to provide better solutions for arterial closure in catheterization procedures. The company has pioneered a unique approach to safely maximize patient comfort and hospital resource efficiencies by revolutionizing arterial access to improve closure. Arstasis is a privately-owned medical device company founded in 2004.

Boston Scientific Corp

Company Type: Parent

In 1969, fascinated by the possibility of bringing pioneering medical devices and treatments to patients across the world, John Abele joined Medi-Tech, a company that was developing alternatives to traditional surgery. Pete Nicholas was looking for an investment, and when he met John, the pieces came together.

Chase Medical Inc

Company Type: Parent

Chase Medical is a privately held medical device company, based in the United States, dedicated to the field of cardiac surgery. For the past 15 years, Chase Medical has been developing and marketing devices specifically for cardiac surgeons. Today, we continue to work closely with cardiac surgeons and clinicians to innovate and aid in the quest for improved outcomes for patients with advanced cardiovascular disease. Chase invest in the future of cardiac surgery, to dedicate our resources to improving the tools for cardiac surgery and to allow hospitals to make cost effective choices while providing excellence in care for patients.

FlowCardia Inc

Company Type: Parent

1-4 of 4 Match(es).


Sign Up for Free e-newsletters

Medical Product Guide OBG Management Product Zone